tiprankstipranks

Steven Weber Insider Profile

4 Followers
Steven Weber, VP, Controller&Princ Acctg Off at Spyre Therapeutics, holds ― shares in Spyre Therapeutics (Ticker: SYRE), holds 32.24K shares in IGM Biosciences (Ticker: IGMS). Most recently, Steven Weber ― shares of Spyre Therapeutics on ― for an estimated value of ―.
tipranks
Steven Weber

Steven Weber
Spyre Therapeutics (SYRE)
VP, Controller&Princ Acctg Off

Ranked #75,766 out of 99,335 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-25.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$315K
100.00%
0.00%
A breakdown of Steven Weber's holdings

Insider Roles

IGM Biosciences
(IGMS)
CAO
Spyre Therapeutics
(SYRE)
VP, Controller&Princ Acctg Off
Roles that Steven Weber holds in companies

Most Profitable Insider Trade

Stock:
IGM Biosciences
(IGMS)
Rating:Informative Sell
Date:Sep 17, 2024 - Today
Return:+26.30%
The most profitable trade made by Steven Weber

Steven Weber's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Spyre Therapeutics
VP, Controller&Princ Acctg Off
IGM Biosciences
Nov 12, 2024
CAO
Uninformative Buy
$314.85K
List of latest transactions for each holding click on a transaction to see Steven Weber's performance on stock

Steven Weber insider profile FAQ

What is the percentage of profitable transactions made by Steven Weber?
The percentage of profitable transactions made by Steven Weber is 33%.
    What is the average return per transaction made by Steven Weber?
    The average return per transaction made by Steven Weber is -25.30%.
      What stocks does Steven Weber hold?
      Steven Weber holds: SYRE, IGMS stocks.
        What was Steven Weber’s latest transaction?
        Steven Weber latest transaction was an Uninformative Buy of ―.
          What was Steven Weber's most profitable transaction?
          Steven Weber’s most profitable transaction was an Informative Sell of IGMS stock on September 17, 2024. The return on the trade was 26.30%.
            What is Steven Weber's role in Spyre Therapeutics?
            Steven Weber's role in Spyre Therapeutics is VP, Controller&Princ Acctg Off.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.